View Older Stories View More Recent Stories

Jul 31, 2023 08:01AM Form 8-K MDB Capital Holdings, For: Jul 31
Jul 26, 2023 11:08AM Form 424B4 MDB Capital Holdings,
Jul 26, 2023 06:03AM Form EFFECT MDB Capital Holdings,
Jul 20, 2023 01:41PM Form 8-A12B MDB Capital Holdings,
Jul 20, 2023 01:41PM Form S-1/A MDB Capital Holdings,
Jul 6, 2023 03:25PM Form S-1/A MDB Capital Holdings,
Jun 20, 2023 05:56PM Paris finance summit to push development banks to take on more risk -draft
May 8, 2023 04:37PM Form S-1/A MDB Capital Holdings,
Mar 24, 2023 06:02AM Form S-1/A MDB Capital Holdings,
Feb 2, 2023 02:25PM Form S-1/A MDB Capital Holdings,
Jan 11, 2023 11:11AM Global Hemp Group Announces Execution of Binding LOI with Apollon Formularies PLC
Dec 28, 2022 05:10PM Form S-1/A MDB Capital Holdings,
Nov 29, 2022 09:00AM MDB Capital Holdings Announces Third MDB-Launched Company to Achieve FDA Approval
Nov 17, 2022 09:00AM Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)
Nov 17, 2022 09:00AM Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)
Nov 11, 2022 09:15AM MDB Capital Holdings Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
Nov 11, 2022 05:37AM MDB Capital Holdings (MDBH) Announces 833K Share IPO at $12/sh
Nov 10, 2022 05:31PM Form S-1 MDB Capital Holdings,
Jun 23, 2022 06:00AM Form D MDB Capital Holdings,
May 24, 2022 09:00AM Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application
Oct 9, 2019 05:00AM Calidi Biotherapeutics Announces Appointment of Seasoned Biotech Executive George Ng to Board of Directors
Jan 8, 2019 04:11PM Clearsign Combustion (CLIR) and Anthony DiGiandomenico Reach Pact to Refresh ClearSign's Board
Jan 8, 2019 04:05PM ClearSign and Anthony DiGiandomenico Reach Agreement to Refresh ClearSign's Board and Ensure Smooth Management Transition
Sep 10, 2018 05:54AM Sorrento Therapeutics (SRNE) Subsidiary Scilex Announces $140M in Non-Dilutive Royalty-Based Financing for Commercialization of Non-Opioid ZTlido Pain Medication
Sep 10, 2018 04:00AM Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing to Support the Commercialization of Non-Opioid ZTlido™ Pain Medication
Sep 4, 2018 08:00AM Form SC 13D/A Provention Bio, Inc. Filed by: MDB CAPITAL GROUP LLC
Jul 20, 2018 06:06AM Form SC 13D/A Provention Bio, Inc. Filed by: MDB CAPITAL GROUP LLC
Jul 19, 2018 07:33PM Form 4 Provention Bio, Inc. For: Jul 19 Filed by: MDB CAPITAL GROUP LLC
Jul 19, 2018 04:05PM Provention Bio Announces Closing of Upsized Initial Public Offering
Jul 3, 2018 05:04PM Form SC 13D Provention Bio, Inc. Filed by: MDB CAPITAL GROUP LLC
Jul 3, 2018 05:04PM Form 3 Provention Bio, Inc. For: Jul 03 Filed by: MDB CAPITAL GROUP LLC
May 8, 2018 12:04PM Mox Reports long Pulse Biosciences, Inc. (PLSE)
Jan 2, 2018 08:00AM Cue Biopharma Announces Closing of Initial Public Offering
Aug 29, 2017 01:23PM Securities Litigation Partner Robert Weber Joins Sheppard Mullin Century City
Jul 18, 2017 08:02AM Provention Bio, Inc. Announces Clinical Program Focused on Intercepting and Preventing the Onset of Type 1 Diabetes
Jun 26, 2017 08:02AM Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease
May 23, 2017 12:25PM Pulse Biosciences, Inc. (PLSE) Lower as TheStreetSweeper Out Negative, Sees 92% Downside
Apr 20, 2017 11:07AM Aqua Metals (AQMS) Ticks Lower Following Cautious Mention on SA
Apr 10, 2017 05:01PM Media Startup TheMaven Network Inc. Completes Private Placement Raising $3.7 Million
Jan 25, 2017 05:55PM ClearSign Combustion Corporation Closes Rights Offering for Gross Proceeds of $9.6 Million
Jan 24, 2017 08:00AM ClearSign Combustion Corporation Updates Information on Rights Offering
Jan 24, 2017 07:30AM Cue Biopharma Debuts With $26 Million in Invested Capital to Develop Next-Generation Biologics to Selectively Control T Cell Activity
Dec 7, 2016 08:00AM ClearSign Combustion Corporation Announces Rights Offering
Nov 4, 2016 08:09AM Clean Diesel Technologies (CDTI) Enters $10.3M Private Placement Equity Raise
Nov 4, 2016 08:00AM CDTi Announces Signing of Securities Purchase Agreement to Raise Approximately $10.3 Million
Oct 18, 2016 07:22AM New Digital Media Network, "theMaven," Announced by James Heckman and Former Scout Executive Team; Sign Acquisition Agreement to Become a Public Company
Aug 11, 2016 11:47AM TheStreetSweeper Cautious on Energous (WATT)
Jun 24, 2016 09:40AM Global Intellectual Property Firm Murgitroyd Expands Strategic & Search Capabilities
Jun 21, 2016 07:00PM Pulse Biosciences Announces Closing of Initial Public Offering Over-allotment
May 23, 2016 04:00PM Pulse Biosciences Announces Closing of Initial Public Offering
View More Recent Stories View Older Stories